Rocephine + Lidocaine IM 1 g + 35 mg/3,5 ml inj. sol. (pwdr. + solv.) i.m. vial + amp.

Country: Belgía

Tungumál: enska

Heimild: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Kauptu það núna

Virkt innihaldsefni:

Ceftriaxone Disodium 1193 mg - Eq. Ceftriaxone 1 g (powder); Lidocaine Hydrochloride 10 mg/ml (solvent)

Fáanlegur frá:

Roche SA-NV

ATC númer:

J01DD04

INN (Alþjóðlegt nafn):

Ceftriaxone (Di)Sodium; Lidocaine Hydrochloride

Skammtar:

1 g + 35 mg/3,5 ml

Lyfjaform:

Powder and solvent for solution for injection

Samsetning:

Ceftriaxone (Di)Sodium 1193 mg; Lidocaine Hydrochloride 10 mg/ml

Stjórnsýsluleið:

Intramuscular use

Lækningarsvæði:

Ceftriaxone

Vörulýsing:

CTI code: 129927-02 - Pack size: 5 x (1 g + 3.5 ml) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 129927-01 - Pack size: 1 g + 3.5 ml - Commercialisation status: YES - FMD code: 07613326003391 - CNK code: 0800912 - Delivery mode: Medical prescription

Leyfisstaða:

Commercialised: Yes

Leyfisdagur:

1984-12-05

Skjöl á öðrum tungumálum

Upplýsingar fylgiseðill Upplýsingar fylgiseðill þýska 06-04-2023
Upplýsingar fylgiseðill Upplýsingar fylgiseðill franska 06-04-2023
Vara einkenni Vara einkenni franska 06-04-2023
RMP RMP franska 25-10-2022
Upplýsingar fylgiseðill Upplýsingar fylgiseðill hollenska 06-04-2023
Vara einkenni Vara einkenni hollenska 06-04-2023
RMP RMP hollenska 25-10-2022